Delivery Order SPE2DB20D7061-SPE2DB23FSPK6
- Not listed
- This federal contract award is for the delivery of the pharmaceutical product Venofer 100 mg/5 ml vial, 5 ml, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $1,858.84 and a completion date of May 30, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Venofer 200 mg/10 ml vials. The contract has a ceiling value of $2,555.60 and a performance period ending on May 6, 2025. This award is not set-aside and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- The summary is as follows: This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $7,203.58, is for the delivery of Venofer 100 mg/5 ml vial (5 ml) to support military and government healthcare programs. The contract has an ultimate completion date of April 29, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,205 units of the pharmaceutical product Venofer 100 mg/5 ml vial, with a total ceiling value of $1,108.00. The contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a child...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,370.46 firm-fixed-price delivery order is for the pharmaceutical product Venofer 100 mg/5 ml vial 5 ml. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,027.36 firm-fixed price delivery order is for VENOFER 100 MG/5 ML VIAL 5ML, a medical product, with a completion date of March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product. The award is a delivery order with a firm fixed price of $1,022.90 and an ultimate completion date of January 29, 2025. This contract award is not designated with a set-aside requirement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,107.34 firm fixed-price delivery order is for the supply of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product. The award is not a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, designated as SPE2DX, which provides global pharmaceutical support to...
- This federal contract award, identified as SPE2DB22D2206|SPE2DB25FFJ16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,859.15, is for the delivery of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product. This contract is a delivery order and has a firm fixed-price pricing type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award, identified as SPE2DB22D3011|SPE2DB23FQ3ME, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,221.09 firm-fixed-price delivery order is for the supply of 100 mg/5 ml vials of the injectable iron supplement Venofer. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB23FSPK6Delivery Order
This federal contract award is for the delivery of Venofer 100 mg/5 ml vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 20, 2023, with a total ceiling value of $4,239.04. The contract is a Firm Fixed Price Delivery Order with a completion date of May 22, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 5/20/23 |